| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.37 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.24 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.09 |